2. 参考文献/ 出处
1. Rogers, J. V., C. L. Sabourin, Y. W. Choi, W. R. Richter, D. C. Rudnicki, K. B. Riggs, M. L. Taylor, and J. Ch a ng.
2005. Decontamination assessment of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus
spores on indoor surfaces using a hydrogen peroxide gas generator. J . Appl.Microbiol. 99:739-748.
2. Bacillus anthracis (Anthrax) deactivation investigation. Defence Science and Technology
Laboratory (Dstl), Porton Down UK. 2002.
3. Kokubo, M., T. Inoue, and J. Akers. 1998. Resistance of common environmental spores
of the genus Bacillus to vapor hydrogen peroxide. PDA.J.Pharm.Sci.Technol. 52:228 - 231.
4. McDonnell, G., G. Grignol, and K. Antloga. 2002. Vapour-phase hydrogen peroxide decontamination of
food contact surfaces. Dairy.Food.Environ.Sanitat. 22:868-873.
5. Spaulding, E. H. 1972. Chemical disinfection and antisepsis in the hospital. J.Hosp.Res. 9:5 - 31.
6. Rickloff, J. R. and reliski, P. A. 1989. Resistance of various micro-organisms to vaporized hydrogen peroxide in
prototype tabletop sterilizer. 89 th General Meeting of the American Society for Microbiology (ASM). New
Orleans.
7. Cabinet bio-decontamination trial. March 1995. Health Protection Agency (previously
Centre for Applied Microbiology and Research), Porton Down UK. 1995.
8. US Environmental Protection Agency (EPA) registered steril a nt. EPA registration number
72372-1 - 86703. 2009.
9. Johnston, M. D., S. Lawson, and J. A. Otter. 2005. Evaluation of hydrogen peroxide vapour as a method for the
decontamination of surfaces contaminated with Clostridium botulinum spores. J.Microbiol.Methods. 60:403 - 411.
10. Boyce, J. M., N. L. Havill, J. A. Otter, L. C. McDonald, N. M. Adams, T. Cooper,
A. Thompson, L. Wiggs, G. Killgore, A. Tauman, and J. Noble - Wang. 2008. Impact of hydrogen peroxide
vapor room decont a mination on Clostridium dif f icile environmental contamination and transmission in a
healthcare setting. Infect.Control.Hosp.Epidemiol.
29:723-729.
11. Otter, J. A. and G. L. French. 2009. Survival of nosocomial bacteria and spores on surfaces and inactivation
by hydrogen peroxide vapor. J.Clin.Microbiol. 47:205 - 207.
12. Case study f rom a room bio-decontamination at Imperial College School of Medicine.
2003. Contact Bioquell for further details.
13. Hall, L., J. A. Otter, J. Chewins, and N. L. Wengenack. 2007. Use of hydrogen peroxide vapor for deactivation of
Mycobacterium tuberculosis in a biological safety cabinet and a room. J.Clin.Microbiol. 45:810 - 815.
14. French, G. L., J. A. Otter, K. P. Shannon, N. M. Adams, D. Watling, a nd M. J. Parks.
2004. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus
(MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination.
J.Hosp.Infect. 57:31-37.
15. Otter, J. A., M. Cummins, F. Ahmad, van Tonder C., and Y. J. Drabu. 2007. Assessing the biological ef f icacy and
rate of recontamin a tion following hydrogen peroxide vapour decontamination. J.Hosp.Infect. 67:182-188.
16. Jeanes, A., G. Rao, M. Osman, and P. Merrick. 2005. Eradication of persistent environmental MRSA.
J.Hosp.Infect. 61:85-86.
17. Dryden, M., R. Parnaby, S. Dailly, T. Lewis, K. Davis - Blues, J. A. Otter, and A. M. Kearns.
2008. Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin- resistant Staphylococcus
aureus outbreak on a surgical ward. J.Hosp.Infect. 68:190-192.
18. Determination of the effectiveness of VPHP against methicillin-resistant Staphylococcus aureus,
Staphylococcus epidermidis and Bacillus stearothermophilus. Health Protection Agency (previously Centre for
Applied Microbiology and Research),
Porton Down UK. 2001.
19. Assessment of the ef f icacy of vapour phase hydrogen peroxide as a room disinfectant. Health Protection Agency
(previously Centre for Applied Microbiology and Research), Porton Down UK. 2003.
20. Otter, J. A., S. Yezli, M. A. Shouten, A. R. van Zanten, G. Houmes - Zielman, and M. Nohlmans-Paulssen.
2010. Hydrogen peroxide vapor (HPV) decontamin a tion of an intensive care unit to remove
environmental reservoirs of multidrug-resist a nt
Gram - negative rods during an outbreak. Am.J.Infect.Control, accepted.
21. Bates, C. J. and R. Pearse. 2005. Use of hydrogen peroxide vapour for environmental control during a Serratia
outbreak in a neonatal intensive care unit. J.Hosp.Infect.
61:364-366.
22. Rogers, J. V., W. R. Richter, M. Q. Shaw, a nd Y. W. Choi. 2008. Vapour - phase hydrogen peroxide inactivates
Yersinia pestis dried on polymers, steel, and glass surfaces. Lett.Appl.Microbiol. 47:279-285.
23. Otter, J. A., J. Chewins, D. Windsor, and H. Windsor. 2008. Microbiological contamination
in cell culture: a potential role for hydrogen peroxide vapour (HPV)? Cell.Biol.Int.
32:326-327.
24. Rickloff, J. R. 1990. Use of Vapourized Hydrogen Peroxide for the Bio-decontamination of
Enclosed Areas. Interphex USA Con f erence. New York.
25. Heckert, R. A., M. Best, L. T. Jordan, G. C. Dulac, D. L. Eddington, and W. G. Sterritt.
1997. E f ficacy of vaporized hydrogen peroxide against exotic animal viruses.
Appl.Environ.Microbiol. 63:3916-3918.
26. Adenovirus deactivation trials. Conducted in commercial confidence. 2003. Contact Bioquell for
further details.
27. Viral deactivation trials. Conducted in commercial confidence. 2002. Contact Bioquell
for further details.
28. McDonnell, G., Belete, B., Fritz, C., and Hartling, J. 2001. Room decontamination with vapour hydrogen
peroxide VHP for environmental control of parvovirus. American Association for Laboratory Animal Science(AALAS), Annual meeting. Baltimore, MD.
29. Rudnick, S. N., J. J. McDevitt, M. W. First, and J. D. Spengler. 2009. Inactivating
influenza viruses on surfaces using hydrogen peroxide or triethylene glycol at low vapor concentrations.
Am.J.Infect.Control. 37:813-819.
30. Investigation into the efficacy of hydrogen peroxide vapour in the bio-deactivation of Dengue virus. 2003.
Conducted in commercial confidence. Contact Bioquell for f urther details.
31. Otter, J. A., M. Barnicoat, J. Down, D. Smyth, S. Yezli, and A. Jeanes. 2010. Hydrogen peroxide vapor (HPV)
decontamination of an intensive care unit room used to treat a patient with Lassa fever. J.Hosp.Infect.in press.
32. Otter, J. A. and A. Budde-Niekiel. 2009. Hydrogen peroxide vapor: a novel method for the environmental
control of lactococcal bacteriophages. J.Food.Prot. 72:412 - 414.
33. Pottage, T., C. Richardson, S. Parks, J. T. Walker, and A. M. Bennett. 2010. Evaluation of hydrogen peroxide
gaseous disinfection systems to decontaminate viruses.
J.Hosp.Infect. 74:55 - 61.
34. Information supplied with kind permission of Eli Lilly and Company, Indianapolis, Indiana.
1996.
35. Hall, L., J. A. Otter, J. Chewins, and N. L. Wengenack. 2008. Deactivation of the dimorphic f ungi
Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor.
Med.Mycol. 46:189-191.
36. Gustin, E. J., McDonnell, G. E., Mullen, G., and Gordon, B. E. 2002. The efficacy of vapour phase hydrogen
peroxide against nematode infestation: the Caenorhabditis ele g ans model. American Association for
Laboratory Animal Science (AALAS), Annual meeting. San Antonio, Texas, USA
37. Krause, J. and Riedesel, H. 2002. Elimination of pinworm eggs from caging equipment with vapourised
hydrogen peroxide. Report from the Max-Planck - Institute for experimental medicine. Association for
Laboratory Animal Science (AALAS) national meeting. San Antonio, Texas, USA
38. Fichet, G., K. Antloga, E. Comoy, J. P. Deslys, a nd G. McDonnell. 2007. Prion inactivation using a new gaseous
hydrogen peroxide sterilisation process. J.Hosp.Infect. 67:278 - 286.
39. DNA degradation studies. Conducted in commercial confidence. 2008. Contact Bioquell
for further details.
Bioquell公司的过氧化氢蒸汽（HPV）作为一种生物消毒剂因其对微生物具有广谱杀菌及快速灭活的功效已在全球各国家/地区得到广泛应用。
首页
